213 related articles for article (PubMed ID: 19509138)
21. [Clinical evaluation of irinotecan combined with cisplatin by divided administration in patients with untreated primary non-small cell lung cancer].
Asano T; Namikawa O; Yamamoto A; Sano T; Mukai J; Kawaji K; Kobayashi M
Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):771-5. PubMed ID: 9866979
[TBL] [Abstract][Full Text] [Related]
22. [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer].
Sugiyama T; Nishida T; Kataoka A; Imaishi K; Komai K; Ushijima K; Hasuo Y; Ookura N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):827-34. PubMed ID: 8841050
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo.
Natsume T; Watanabe J; Koh Y; Fujio N; Ohe Y; Horiuchi T; Saijo N; Nishio K; Kobayashi M
Cancer Sci; 2003 Sep; 94(9):826-33. PubMed ID: 12967483
[TBL] [Abstract][Full Text] [Related]
24. Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells.
Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
Cancer Gene Ther; 2000 Feb; 7(2):300-7. PubMed ID: 10770640
[TBL] [Abstract][Full Text] [Related]
25. Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect.
Matsumura Y
Adv Drug Deliv Rev; 2011 Mar; 63(3):184-92. PubMed ID: 20561951
[TBL] [Abstract][Full Text] [Related]
26. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
[TBL] [Abstract][Full Text] [Related]
27. [Advantages in combination chemotherapy using the camptothecin analogue CPT-11 and cisplatinum analogues for human testicular cancer xenografts].
Miki T; Kotake T
Hinyokika Kiyo; 1993 Dec; 39(12):1221-5. PubMed ID: 8285173
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo effects of cisplatin and etoposide in combination on small cell lung cancer cell lines.
Kondo H; Kanzawa F; Nishio K; Saito S; Saijo N
Jpn J Cancer Res; 1994 Oct; 85(10):1050-6. PubMed ID: 7961107
[TBL] [Abstract][Full Text] [Related]
29. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
[TBL] [Abstract][Full Text] [Related]
30. IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy.
Ferté C; Loriot Y; Clémenson C; Commo F; Gombos A; Bibault JE; Fumagalli I; Hamama S; Auger N; Lahon B; Chargari C; Calderaro J; Soria JC; Deutsch E
Mol Cancer Ther; 2013 Jul; 12(7):1213-22. PubMed ID: 23640142
[TBL] [Abstract][Full Text] [Related]
31. Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.
Fukuda M; Nishio K; Kanzawa F; Ogasawara H; Ishida T; Arioka H; Bojanowski K; Oka M; Saijo N
Cancer Res; 1996 Feb; 56(4):789-93. PubMed ID: 8631015
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer.
Isobe T; Onn A; Morgensztern D; Jacoby JJ; Wu W; Shintani T; Itasaka S; Shibuya K; Koo PJ; O'Reilly MS; Herbst RS
J Thorac Oncol; 2013 Feb; 8(2):140-6. PubMed ID: 23328546
[TBL] [Abstract][Full Text] [Related]
33. Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer.
Yanagihara K; Takigahira M; Kubo T; Ochiya T; Hamaguchi T; Matsumura Y
Ther Deliv; 2014 Feb; 5(2):129-38. PubMed ID: 24483192
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of a new anti-cancer drug regimen for surface epithelial-stromal ovarian cancer].
Fushiki H; Hidaka T; Hori S; Fujimura M; Yamakawa Y; Izumi R
Gan To Kagaku Ryoho; 1998 Apr; 25(5):731-4. PubMed ID: 9571971
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
Fukuda M; Ohe Y; Kanzawa F; Oka M; Hara K; Saijo N
Anticancer Res; 1995; 15(2):393-8. PubMed ID: 7763011
[TBL] [Abstract][Full Text] [Related]
36. Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
Kumazawa E; Jimbo T; Ochi Y; Tohgo A
Cancer Chemother Pharmacol; 1998; 42(3):210-20. PubMed ID: 9685056
[TBL] [Abstract][Full Text] [Related]
37. Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer.
Lee DH; Kim SW; Suh C; Lee JS; Ahn JS; Ahn MJ; Park K; Na II; Lee JC; Ryoo BY; Yang SH
Cancer; 2010 Jan; 116(1):132-6. PubMed ID: 19904804
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.
Cheng YS; Peng YB; Yao M; Teng JP; Ni D; Zhu ZJ; Zhuang BF; Yang ZY
Biochem Biophys Res Commun; 2017 Jun; 487(3):567-572. PubMed ID: 28431928
[TBL] [Abstract][Full Text] [Related]
39. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin down-regulates topoisomerase I activity in lung cancer cell lines.
Aoe K; Kiura K; Ueoka H; Tabata M; Chikamori M; Kohara H; Harada M; Tanimoto M
Anticancer Res; 2004; 24(6):3893-7. PubMed ID: 15736428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]